Patient Stimulation and Effect on Outcomes
Publisher
Springer New York
Reference42 articles.
1. Meldrum, DR. GnRH agonists as adjuncts for in vitro fertilization. Obstet Gynecol Surv 1989;44:314–18.
2. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888–96.
3. Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Marrs RP. An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 1988;49:90–95.
4. Cedars MI, Surey E, Hamilton F, Lapolt P, Meldrum DR. Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. Fertil Steril 1990;53:627–31.
5. Smitz J, Camus M, Devroey P, Erard P, Wisanto A, Van Steirtegham AC. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonistJHMG superovulation for in-vitro fertilization. Hum Reprod 1990;5:933–37.